- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1897-4287
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Drug therapy for hereditary cancers ; volume:9 ; number:1 ; day:6 ; month:8 ; year:2011 ; pages:1-16 ; date:12.2011
Hereditary cancer in clinical practice ; 9, Heft 1 (6.8.2011), 1-16, 12.2011
- Creator
-
Imyanitov, Evgeny N.
- Contributor
-
Moiseyenko, Vladimir M.
SpringerLink (Online service)
- DOI
-
10.1186/1897-4287-9-5
- URN
-
urn:nbn:de:1111-201607102002
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Imyanitov, Evgeny N.
- Moiseyenko, Vladimir M.
- SpringerLink (Online service)
Other Objects (12)
Cytotoxic and targeted therapy for hereditary cancers
Hereditary Ovarian Cancers
Systemic treatment for hereditary cancers: a 2012 update
Systemic therapy for hereditary cancer
Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites
Targeting KRAS mutant cancers: from druggable therapy to drug resistance
Targetting brain cancers: approaches for therapy
Rare Cancers and Therapy
AAV‐mediated Gene Therapy for Hereditary Deafness: Progress and Perspectives
Development of novel high-efficacy drugs targeting replication protein A3 in therapy resistant cancers
Cytotoxic and targeted therapy for BRCA1/2-driven cancers
Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances
Cytotoxic and targeted therapy for hereditary cancers
Hereditary Ovarian Cancers
Systemic treatment for hereditary cancers: a 2012 update
Systemic therapy for hereditary cancer
Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites
Targeting KRAS mutant cancers: from druggable therapy to drug resistance
Targetting brain cancers: approaches for therapy
Rare Cancers and Therapy
AAV‐mediated Gene Therapy for Hereditary Deafness: Progress and Perspectives
Development of novel high-efficacy drugs targeting replication protein A3 in therapy resistant cancers
Cytotoxic and targeted therapy for BRCA1/2-driven cancers
Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances
Cytotoxic and targeted therapy for hereditary cancers
Hereditary Ovarian Cancers
Systemic treatment for hereditary cancers: a 2012 update
Systemic therapy for hereditary cancer
Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites
Targeting KRAS mutant cancers: from druggable therapy to drug resistance
Targetting brain cancers: approaches for therapy
Rare Cancers and Therapy
AAV‐mediated Gene Therapy for Hereditary Deafness: Progress and Perspectives
Development of novel high-efficacy drugs targeting replication protein A3 in therapy resistant cancers
Cytotoxic and targeted therapy for BRCA1/2-driven cancers